Vaishali Pharma Ltd

Vaishali Pharma Ltd Share Price Today: Live Updates & Key Insights

Get insights on Vaishali Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Vaishali Pharma Ltd Share Price Chart

Vaishali Pharma Ltd Fundamentals

Traded Volume: 1,20,122

Market Cap(Cr): 104

Avg Traded Price 8.94

1 Year return -46.95%

Upper Circuit 9.9

Lower Circuit 9.5

P/E TTM 320.00

P/B Ratio 0.00

Traded Value(Cr) 11.70

EPS TTM 0.030

Book value 0.030

Dividend 0.00%

Vaishali Pharma Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Vaishali Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Vaishali Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -3.28%

1M -14.34%

3M -24.90%

1Y -46.95%

YTD -44.78%

Vaishali Pharma Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Vaishali Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 4.14L

Day Before Yesterday 3.51L

1W Avg 4.15L

1M Avg 4.54L

3M Avg 4.10L

Vaishali Pharma Ltd Technical Details

Vaishali Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 10

Support 2 9

Support 3 9

Pivot Point : 10

Resistance 1 10

Resistance 2 10

Resistance 3 10

Vaishali Pharma Ltd Corporate Actions

Vaishali Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Vaishali Pharma Ltd’s capital allocation strategies.

All

Ex-Date 15-Oct-2024 Type B Description share@1:1 Record Date 15-Oct-2024 Ratio 1:1

Ex-Date 15-Oct-2024 Type S Description share@1:5.00 Record Date 15-Oct-2024 Ratio 1:5.00

Ex-Date 17-Oct-2019 Type B Description share@3:5 Record Date 18-Oct-2019 Ratio 3:5

Dividends

No Dividend has been declared by VAISHALI

Bonus

Record Date 15-Oct-2024 Ex-Bonus Date 15-Oct-2024 Ratio 1:1

Record Date 18-Oct-2019 Ex-Bonus Date 17-Oct-2019 Ratio 3:5

Splits

Record Date 15-Oct-2024 Split Date 15-Oct-2024 Face Value (Before/After) 10.00/2.00

Others

Rights No Rights has been declared by VAISHALI

Vaishali Pharma Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Vaishali Pharma Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Vaishali Pharma Ltd's relative performance and valuation against major competitors.

Stock Name Achyut Healthcare Ltd ₹5.60 (+1.45%) M. Cap (Cr) 1.32 1 Yr Return (%) +15.23% P/E (TTM) 234.41 PB Ratio 4.17

Stock Name Bal Pharma Ltd ₹81.86 (+1.87%) M. Cap (Cr) 1.30 1 Yr Return (%) -34.88% P/E (TTM) 18.21 PB Ratio 1.68

Stock Name Tyche Industries Ltd ₹124.95 (-6.12%) M. Cap (Cr) 1.28 1 Yr Return (%) -37.91% P/E (TTM) 10.50 PB Ratio 0.94

Stock Name Vaishali Pharma Ltd ₹9.74 (-1.02%) M. Cap (Cr) 1.04 1 Yr Return (%) -46.95% P/E (TTM) 319.55 PB Ratio 1.88

Stock Name Denis Chem Lab Ltd ₹90.25 (-1.63%) M. Cap (Cr) 1.25 1 Yr Return (%) -43.38% P/E (TTM) 14.79 PB Ratio 1.47

Stock Name Par Drugs & Chemicals Ltd ₹98.73 (-0.45%) M. Cap (Cr) 1.21 1 Yr Return (%) -66.98% P/E (TTM) 8.58 PB Ratio 1.26

Stock Name Auro Laboratories Ltd ₹183.35 (-1.85%) M. Cap (Cr) 1.14 1 Yr Return (%) -28.48% P/E (TTM) 163.90 PB Ratio 2.66

Vaishali Pharma Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Vaishali Pharma Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 -18.04 Mar 2024 0.81 Mar 2023 1.08

PARTICULARS Investing Activities Mar 2025 -0.19 Mar 2024 1.20 Mar 2023 0.28

PARTICULARS Financing Activities Mar 2025 18.49 Mar 2024 -1.42 Mar 2023 -1.73

PARTICULARS Net Cash Flow Mar 2025 0.26 Mar 2024 0.59 Mar 2023 -0.37

Vaishali Pharma Ltd Shareholding Pattern

This shows the ownership breakdown of Vaishali Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 26.32%

Public 73.68%

Other Institutions 0%

FII null%

Mutual Funds null%

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries; of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Company's synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients.In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments & Medical Devices Directive. In addition, the Company has also been recognized by Government of India as 'One Star Export House' and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.

Chairman & Managing Director

Atul Vasani

Registered office 706 to 709 7th Floor Aravali, Business Centre Borivali(W), Mumbai, Maharashtra, 400092

FAX :91-22-28928833

Background

Incorporation Year 2008

Face Value ₹2.00

Market Lot 1

Vaishali Pharma Ltd Latest News

VIEW MORE NEWS

FAQs on Vaishali Pharma Ltd